Project Details
Description
Development of Selective, Allosteric Inhibitors of Cyclin-Dependent Kinase 2 for theTherapeutic Treatment of Cancer
| Status | Active |
|---|---|
| Effective start/end date | 9/1/23 → 8/31/25 |
Funding
- AMERICAN FDN FOR PHARMACEUTICAL EDUC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.